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Abstract  
BACKGROUND: Vesicoureteric reflux (VUR) is an important association of paediatric urinary tract infection (UTI) 
found in 30-50% of all children presenting with first UTI. Contrast-enhanced voiding ultrasonography (ceVUS) has 
become an important radiation-free method for VUR detection in children. Its sensitivity in detecting VUR has 
greatly improved due to the development of the contrast-specific ultrasound techniques and the introduction of the 
second-generation ultrasound contrast agent, superseding the diagnostic accuracy of standard radiological 
procedures. 
 
AIM: This article aimed to summarise the current literature and discuss the first local pilot study performed in our 
institution on detection of vesicoureteric reflux by contrast-enhanced voiding ultrasonography with second- 
generation agent (SonoVue, Bracco, Italy). 
 
MATERIAL AND METHODS: Retrospective review of the first 31 ceVUS (24 girls, 7 boys) was presented.  Age 
range was 2 months to 18 years (mean = 6.4 ± 4.9). 
RESULTS:  All examinations were well tolerated without any adverse incident. VUR was shown in 20 (64.5%) 
children in 32/62 (51.6) nephroureteral units (NUUs). In 18 NUUs, VUR was grade II/V, in 11 Grade III/V and in 3 
grade IV/V, respectively. Urethra was shown in 19/31 children and in all boys, without pathological finding. In two 
girls spinning top urethra has been detected. Subsequent urodynamic studies revealed functional bladder problem 
in both.   
CONCLUSIONS: Contrast-enhanced voiding urosonography using intravesical second generation ultrasound 
contrast agent could be recommend  as a valid alternative diagnostic modality for detecting vesicoureteral reflux 
and evaluation of the distal urinary tract in children, based on its radiation-free, highly efficacious, reliable, and 
safe characteristics. 
 
 
 
 
 
Introduction 
 
Vesicoureteric reflux refers to the abnormal 
retrograde flow of urine from the urinary bladder back 
into the ureter or, even, to the kidney. Its prevalence 
in general population is around 1% may be higher. It 
is identified in 30-50% of all children presenting with a 
first UTI and in 27.4% of siblings of patients with 
documented VUR [1-5]. It is not only a developmental 
anomaly related to the inadequate length of the 
intravesical submucosal ureter but also a 
dysfunctional problem in which many patients have 
associated bladder emptying and bowel dysfunction 
[6]. For decades, it has been thought to be associated 
with reflux nephropathy (RN) and renal scarring 
[7]. It
 
is now evident that there is a sex difference in 
the development
 
of RN. In most males with RN, the 
kidneys are congenitally abnormal suggesting and 
embryological abnormality. In females, it is an 
acquired condition, the most severe damage
 
being 
sustained by recurrent urinary tract infections.
 
It is 
recommended to exclude vesicoureteric reflux in high-
risk patients, including those with hydronephrosis, 
renal scarring, or other findings that suggest high-
grade vesicoureteric reflux or obstructive uropathy on 
renal ultrasound, and in those suffering from atypical 
UTI or complex clinical circumstances [8]. 
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Three types of voiding cystography are 
currently used to identify VUR, namely, X-ray voiding 
cystourethrography (VCUG], radionuclide voiding 
cystography (RNC], and contrast-enhanced voiding 
ultrasonography (ceVUS]. The voiding cystography 
differentiate according to the type of contrast agent 
installed in the bladder and the equipment required for 
depicting the contrast agent. All of these techniques 
require catheterization of the urinary bladder. Also, 
VCUG and RNC involve exposure to ionising 
radiation. Contrast-enhanced voiding ultrasonography, 
previously known as reflux sonography, 
cystosonography, and echo-enhanced cystography [9-
11] does not involve ionising radiation. It involves the 
intravesical application of ultrasound contrast and 
normal saline continuous sonographic examination of 
the bladder, kidneys and retrovesical region during 
and after bladder filling and finally during voiding. 
Hereby the observer assesses whether microbubles 
ascend to the ureters and the kidneys in a case of 
vesicoureteral reflux. 
 
ceVUS has been accepted as a routine 
radiation-free method for diagnosis of VUR in many 
European centres and from the recently in our 
institution. We here describe our initial experience 
with ceVUS using the second generation US contrast 
agent SonoVue. We are focusing on optimisation of 
examination technique, observation of reflux and 
discussion of potential pitfalls.
 
 
 
Materials and Methods 
 
This is a retrospective review of first 31 
ceVUS studies, 24 girls and 7 boys. The age range 
was 2 months to 18 years (mean: 6.4 ± 4.9). 
 
Technique 
All US examinations were performed using a 
Voluson E6 high-definition scanner (GE Healthcare) 
equipped with HI mode and "contrast-tuned imaging", 
contrast-specific harmonic software dedicated to 
second generation contrast agents and based on 
maintenance of microbubbles at low acoustic pressure 
with subtractive imaging techniques. This software 
also enables colour coding of the conventional B-
mode signal to improve resolution. Contrast imaging 
at all ages was performed with a phased-array convex 
2.5–5-MHz probe prepared for this purpose. The 
mechanical index (MI) setting ranged between 0.08 
and 0.16 in the low-MI contrast specific mode to 
minimise the breakage of microbubbles and to prolong 
the observation time.
 
A preliminary US study of kidneys, ureter and 
bladder was performed to evaluate the renal size, 
parenchymal echo structure and presence of 
pelvicalyceal or ureteric dilatation. 
 
A 6F or 8F infant feeding tube was inserted 
into the urinary bladder under aseptic conditions. The 
bladder was emptied and then filled slowly with saline 
solution from a 500 ml plastic bottle kept at body 
temperature [12, 13] and placed about 80 cm above 
the examination table. 1 ml of the second-generation 
US contrast agent SonoVue was injected into the 
bottle and gently shakes to homogenize the contents 
ensuring the correct mixture of contrast agent and 
saline solution and thus avoiding the accumulation of 
contrast material in the anterior aspect of the bladder 
which could cause an acoustic shadow that would 
impede the correct study of the bladder due to the 
difficulty of dissolving the contrast agent with its 
greater molecular weight. Within seconds of the start 
of bladder filling with the suprapubic approach, 
contrast material has been observed being 
progressively and homogenously incorporated, 
bringing about generalised distention or filling the 
bladder. The bladder is well defined by the hypo 
echoic band that corresponds to the bladder wall, and 
the normal detrusor muscle is seen in the posterior 
inferior aspect.  
When we observe correct filling, it coincides 
with clinical symptoms such as crying and flexion of 
the toes. At this point, we consider that we have 
reached the maximum capacity of the bladder, and we 
acquire images in the transverse and sagittal planes 
of the bladder and calculate its volume. 
 
Immediately after the end of the first voiding, 
which was carried out with the catheter left in the 
bladder, the second cycle of VUS was performed with 
the same procedural steps except that no additional 
contrast agent was injected [14]. 
 
Simultaneously during filling phase and 
voiding through the catheter, we studied the kidneys 
by alternating between longitudinal and cross-
sectional slices with the patient in the supine position. 
In the renal study, we are especially careful to detect 
VUR, defined as the presence of microbubbles of 
contrast material in the pyelocaliceal system and 
ureters. To grade VUR, we used the five-level grading 
system adapted to VUS [Darge Treger 25]: Grade I 
Microbubbles only in the ureter; Grade II Microbubbles 
in the renal pelvis; no significant renal pelvic dilatation; 
Grade III Microbubbles in the renal pelvis + significant 
renal pelvic dilatation + moderate calyceal dilatation; 
Grade IV Microbubbles in the renal pelvis + significant 
renal pelvic dilatation + significant calyceal dilatation; 
Grade V Microbubbles in the renal pelvis + significant 
renal pelvic dilatation and calyceal dilatation + loss of 
renal pelvis contour + dilated tortuous ureters. 
To evaluate the urethra, we use a 
transperineal approach, placing the probe in the 
sagittal plane in all boys, regardless of age, and we 
also use a suprapubic approach in infants and a case 
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of urgent voiding. A trans pelvic approach was used 
for the study of the urethra in girls (placing the convex 
transducer sagittally against the suprapubic area of 
the abdominal wall); however, in older girls, a 
longitudinal interlabial approach was also used. 
 
 
Figure1: Contrast-enhanced voiding ultrasonography. Bladder filled 
with ultrasound contrast agent (B-mod "grayscale", left and B-mod + 
contrast specific software (right)
 
 
The urethra is considered normal when we 
see adequate distention and normal calibre along its 
entire length, with a continuous progression of 
contrast material toward the exterior during voiding. 
As reference values for distention during voiding, we 
use 6.4 ± 0.78 mm for the posterior urethra and 5.8 ± 
0.91 mm for the anterior urethra. The difference in the 
calibre of the posterior and anterior urethra is between 
0-2 mm. For the female urethra, we used 9.5 ± 1.1 
mm as the reference value [15]. Continuous images of 
voiding were obtained in real time. Lastly, we 
evaluated residual urine and the urethra after voiding. 

 
 
Figure 2: Ultrasound contrast agent in the collecting system of the 
right kidney using contrast specific software, B-mod "grayscale" 
(left) B-mod + contrast specific software (right)
 
The entree study (from the time the patient is 
admitted to the examination room until the end of the 
test) does not differ from that necessary for VCUG 
(25-30 min).  
 
Figure 3: Spinning Top Urethra, using contrast specific software,  B-
mod “grayscale” (left), B-mod + contrast specific software (right) 
 
The ceVUS study is digitally recorded and 
stored on a hard drive. It is obtained in all cases and 
available for review (Fig. 1-4). All children were placed 
on antibiotic prophylaxis for 3 days including the day 
of the examination (cefixime 8 mg/kg body weight, 
once a day in infants <3 months of age, and 
trimethoprim-sulfamethoxazole 6 mg/kg per day 
divided into two equal doses in children >3 months of 
age). Any adverse events related to a contrast agent, 
including acute or late allergic reactions, observed 
during the 6-h stay in the clinic or the next 24 h follow-
up by phone reported by the patients were recorded.
 
 
Figure 4: Normal transpubic view of the male urethra, using contrast 
specific software, B-mod “grayscale” (left), B-mod + contrast 
specific software (right) 
 
 
Results 
 
A total of 31 children with 62 nephroureteral 
units (NUUs) were evaluated. Indications for ceVUS 
were acute pyelonephritis and recurrent urinary tract 
infection (16 children), hydronephrosis /small kidney 
(5 children] and control investigation for VUR during 
conservative management or after endoscopic 
correction (10 children]. All examinations were well 
tolerated without any adverse incident. 
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VUR was shown in 20 (64.5%] children in 
32/62 (51.6) NUUs. It was unilateral in 8 and bilateral 
in 12 children. In 18 NUUs VUR was grade II/V in 11 
Grade III/V and 3 grade IV/V respectively. 
 
The urethra was shown in 19/31 children and 
all boys, without a pathological finding. In two girls 
spinning top urethra has been detected. Subsequent 
urodynamic studies revealed functional bladder 
problem in both.  
 
 
Discussion 
 
Conventional reflux imaging modalities for 
diagnosing VUR include voiding cystourethrography 
and radionuclide cystography. 
Voiding cystourethrography has been the gold 
standard of imaging for diagnosing and grading 
vesicoureteric reflux. The procedure involves bladder 
catheterization and intravesical administration of 
radiographic contrast via the urinary catheter, followed 
by a fluoroscopic examination of the lower abdomen 
and pelvis. The presence of opacification of the upper 
urinary tract with radiographic contrast during bladder 
filling and voiding phases is diagnostic of 
vesicoureteric reflux. A standardised international 
system is used for grading the reflux [16].Voiding 
cystourethrography involves fluoroscopy and, thus, 
exposure to ionising radiation. The standard mean 
effective dose of VUCG is approximately 0.4 to 0.9 
mSv [17]. To reduce radiation exposure in both 
patients and operators, intermittent fluoroscopic 
screening and last image hold on pulsed digital 
fluoroscopy are employed. Nevertheless, children are 
more susceptible than adults to the long-term hazards 
of radiation, because growing tissues in children are 
more sensitive to radiation effects than the fully 
mature tissues of adults. Furthermore, children have 
longer life expectancy during which potential 
oncogenic effects of radiation may be manifested [17]. 
Recent literature shows a dramatic increase in 
medical radiation burden to children arising from 
radiological examinations with the expansion of 
medical imaging. It is postulated that medical radiation 
can contribute to radiation-induced cancers [17]. 
Hence, radiation exposure is a major drawback of 
VCUG. Of note, as vesicoureteric reflux is an 
intermittent phenomenon it can sometimes be missed 
by intermittent fluoroscopic screening techniques. The 
dilution of a small amount of radiographic contrast in 
the already-dilated collecting contrast and obscuration 
by overlying bowel shadow, also contribute to the 
lower sensitivity of VUCG.
 
Direct RNC also involves bladder 
catheterization and intravesical administration of 
radiopharmaceuticals. It carries the advantages of 
continuous examination of kidneys and bladder during 
the filling phase, and lower gonadal radiation dose. 
The estimated dose to the ovary is 0.005 to 0.01 mSv, 
and even smaller dose to the testis [18]. In general, it 
has a comparable diagnostic performance with 
VCUG, with no significant difference in the detection 
rate [18, 19]. However, owing to its lower spatial 
resolution and impaired anatomical delineation, RNC 
is used for follow-up of patients with known 
vesicoureteric reflux [20]. It is not recommended as 
the first diagnostic test for vesicoureteric reflux, 
particularly in boys due to its limited efficacy in 
examining the urethral abnormality in detail. Besides, 
RNC also involves ionising radiation to both children 
and parents. 
The diagnostic performance of ceVUS was 
only improved since the introduction of stabilised 
ultrasound contrast agent on the intravesical 
application [21] as well as the advances in the 
ultrasound techniques, namely, harmonic imaging 
[22]. Levovist (Levovist Schering, Berlin, Germany] 
was the first generation stabilised ultrasound contrast 
composed of palmitic-acid stabilised microbubbles 
employed in ceVUS. Until its withdrawal in 2011, it 
was commonly used for VUS. Since that time the 
second generation contrast SonoVue (Bracco 
Imaging, Milan, Italy) has remained as the only 
available ultrasound contrast agent ( USCA) in the 
EU. SonoVue has several intrinsic advantages over 
Levovist [23]. SonoVue is a stabilised aqueous 
suspension of sulphur hexafluoride microbubbles with 
a phospholipid shell, which resonates by asymmetric 
contraction and expansion, and strongly increase the 
ultrasound backscatter allowing visualisation. It is not 
readily soluble in water, and, hence, remains stable 
for up to 6 hours. In an in-vitro comparative study with 
Levovist [5% volume] the contrast duration with 
SonoVue was seven times longer at a dose that was 
80% lower [31]. Moreover, the contrast duration of a 
freshly prepared suspension of SonoVue was stable 
over 6 h, whereas Levovist showed a significant 
reduction after 30 min. In addition to the improved 
intrinsic property of ultrasound contrast, tissue 
harmonic imaging technique is now employed in 
ultrasound imaging. Tissue harmonic imaging is 
based on the phenomenon of non-linear distortion of 
an acoustic signal as the ultrasound wave resonates 
and travels through the body tissues. It improves 
contrast and spatial resolution and reduces artefacts 
compared with conventional grayscale ultrasound 
[24]. Together with subtraction technique, contrast-
specific harmonic imaging mode further increases the 
conspicuity of the microbubble. It is important to set a 
mechanical index (MI] below 0.10 in order not to break 
the micro bubbles of the second-generation USCA, 
since with an increase of MI the rate of micro bubbles 
destruction increases. 
The presence of microbubbles in the ureter or 
pelvicalyceal system, appearing as strong 
hyperechoic signals in contrast-harmonic mode, was 
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considered diagnostic of VUR. If it is present VUR is 
graduated in 5 grades according to Drage and 
Troeger comparable with radiographic classification 
[25]. 
Diagnostic performance of ceVUS in 
comparison with VUCG has been elaborated 
extensively. Darge has confirmed the diagnostic 
performance of ceVUS by the first-generation 
stabilised ultrasound contrast Levovist [26]. Using 
VUCG as the reference method, the sensitivity of 
ceVUS ranged from 57% to 100%, and specificity 
from 85% to 100%. The diagnostic accuracy, 
measuring the concordance of both positive and 
negative cases, ranged from 78% to 96%. Currently, 
the second-generation contrast SonoVue-enhanced 
VUS has superior sensitivity ranging from 80% to 
100%, and a specificity of 77% to 97% [13, 27, 28, 29, 
30]. Diagnostic accuracy is similar to that of Levovist, 
at about 80% to 98%. Moreover, SonoVue-enhanced 
VUS has consistently higher reflux detection rate than 
VCUG. Data show that VCUG misses 6% to 62% of 
all reflux units. In the study by Ključevšek et al. [27], 
26 (62%] out of 42 reflux units were additionally 
identified by ceVUS alone, but none by VCUG alone. 
On the other hand, ceVUS misses only 0% to 12% of 
all reflux units. 
 
Therefore, ceVUS is not only highly 
concordant with VCUG on reflux detection, but also 
more sensitive than VCUG. With the use of VCUG, a 
significant number of patients with reflux who may 
need to be on prophylactic antibiotics can be missed. 
Furthermore, the reflux missed by VCUG was 
predominantly of higher grade and thus clinically more 
important than that missed by VUS. The fact that 
VCUG might underestimate or miss reflux may be 
partly explained by the intermittent nature of VUR, the 
potential for marked dilution of contrast agent in a 
dilated system, and the short fluoroscopic time during 
VCUG [26]. Conversely, prolonged observation is an 
advantage of VUS that allows a higher number of 
patients with VUR and possibly higher grades of VUR 
to be diagnosed compared to VCUG. On the other 
hand, the lower detection rate of low-grade reflux on 
ceVUS is attributed to the difficulty in visualising 
retrovesical regions and nondilated ureter related to 
the acoustic shadow cast by the intravesical 
contrast.
 
In our patients, we did not perform 
comparative studies between ceVUS vs. VCUG. 
 
We considered that there is enough evidence 
in the literature for diagnostic performance of ceVUS 
to escape unnecessary radiation.
 
A further advantage of second-generation 
contrast agents in the evaluation of VUR is the use of 
substantially lower volumes compared to first-
generation contrast agents, leading to a significant 
reduction in the cost of the procedure [28, 30, and 31]. 
We used 1 ml of a second generation contrast agent 
that was adequate for making a confident diagnosis of 
VUR. Due to the increased sensitivity of harmonic 
imaging [HI], even sporadic microbubbles can be 
reliably visualised. Because microbubbles after 
reconstitution are stable for approximately 6 h, a 5-ml 
vial could potentially be used for the examination of 
reflux in 5 children.
 
With the application of urethral imaging in 
ceVUS, examination of the urethra is technically 
feasible. Up to introduction of ceVUS, VCUG has 
been used as the only method for evaluation of the 
urethral pathology. By RNC it is not possible to 
visualise urethra. Consequently, for years in the 
evaluation of children with UTI, we have used VCUG 
as a first diagnostic test in boys and RCN in female 
children where there is no significant pathology of the 
urethra. Duran et al. [34] revealed that diagnosis of 
urethral pathologies, such as a posterior urethral 
valve, diverticulum of prostatic utricle, and anterior 
urethral stricture could be achieved by ceVUS, using 
interscrotal and transperineal approaches in boys. In 
our patients, we used transperineal and suprapubic 
trans pelvic approach during urgent voiding. The 
urethra was visualised in most but not in all patients, 
presumably because of their refusing to void. In 
children where the urethra has been shown by 
ceVUS, we did not diagnose any urethral pathology; 
however, from a clinical point of view, it is important 
that we have ruled it out by using radiation-free 
method instead of invasive VCUG. In two girls 
spinning top urethra has been shown (Fig. 3), that can 
be a normal variant, but it is important to rule out 
functional voiding disorder. Indeed, in both patients, 
subsequent urodynamic study confirmed functional 
bladder disturbance. 
 
Echo-enhanced VUS is now described in 
standard paediatric radiology and urology textbooks 
and incorporated into guidelines. The ceVUS had 
been incorporated in the joint guideline for urological 
examination by the European Society of Urogenital 
Radiology [ESUR] and European Society of Pediatric 
Radiology (ESPR) in 2007[35]. The indications of 
ceVUS include follow-up examination of known 
vesicoureteric reflux, investigation of UTI in girls, as 
well as screening for familial history of vesicoureteric 
reflux and fetal hydronephrosis. The application of 
ceVUS has extended to the investigation of UTI in 
boys and urethral imaging in genitogram in the ESUR 
and ESPR guideline 2012 [36]. It is starting to be used 
as the primary imaging modality for all cases of VUR 
detection, regardless of age [27, 32].VCUG is 
reserved for a limited number of patients requiring 
detailed anatomical assessment [32].
 
 In conclusion, in the era of heightened 
radiation awareness and protection, radiation doses to 
infants and children should be kept as low as 
reasonably achievable. Our data indicate that 
contrast-enhanced voiding ultrasonography using 
intravesical second-generation ultrasound contrast 
agent could be introduced as a valid alternative 
diagnostic modality for detecting vesicoureteral reflux 
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and evaluation of the distal urinary tract in children, 
based on its radiation-free, highly efficacious, reliable, 
and safe characteristics. 
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